Three-dimensional conformal radiotherapy for lung cancer: promises and pitfalls.
- 1 July 2002
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 4 (4) , 347-353
- https://doi.org/10.1007/s11912-002-0011-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999
- Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsLung Cancer, 1999
- TomotherapySeminars in Radiation Oncology, 1999
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Respiration gated radiotherapy treatment: a technical studyPhysics in Medicine & Biology, 1996
- Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90-15Cancer, 1995
- Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1995
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI Journal of the National Cancer Institute, 1991